NCT00546650View on ClinicalTrials.gov

Phase I Study to Compare NP101(Sumatriptan Iontophoretic Transdermal Patch) With Three Formulations of Imitrex®

PHASE1CompletedINTERVENTIONAL
Enrollment

25

Participants

Timeline

Start Date

November 30, 2007

Primary Completion Date

December 31, 2007

Study Completion Date

March 31, 2008

Conditions
Healthy
Interventions
DRUG

Sumatriptan succinate

NP101 iontophoretic transdermal system

DRUG

Sumatriptan succinate

oral, subcutaneous, and intranasal formulations

Trial Locations (1)

32809

Orlando Clinical Research Center, Orlando

Sponsors

Lead Sponsor

NuPathe Inc.
All Listed Sponsors
lead

NuPathe Inc.

INDUSTRY